Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients

Fig. 5

Survival differences according to C1RL expression in glioma. High C1RL expression predicted shortened overall survival for glioma patients (a) and primary glioma patients (b-d). High C1RL expression predicted shortened overall survival for GBM patients (e) and primary GBM patients (f-i). Primary GBM with high C1RL expression showed increased resistance to radiochemotherapy (j), resection (k), and standard therapy (l)

Back to article page